Work

P22.02 Combined Use of CYFRA 21-1, CA125 and CRP Predicts Survival of Metastatic NSCLC Patients With Stable Disease

Year: 2021

Type: conference-abstract

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2021.08.356

Authors: A. Mang, W. Zou, V. Rolny, M. Reck, D. Cigoianu, K. Schulze, A. Mazumder, M. Socinski, D. Shames, D. Morgenstern, B. Wehnl, N. Patil

Institutions: Genentech, LungenClinic Grosshansdorf, Roche Diagnostics International AG (Switzerland)

Language: English

Topic: Lung Cancer Research Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3207582348

Cites:

Cited by: 2

Related to: 10